Answer
No, breastfeeding is advised against during Alecensa (alectinib hydrochloride) treatment because it is unknown whether alectinib or its metabolites enter human milk, and a risk to the newborn or infant cannot be excluded.
Sources for this answer
- Alecensa 150 mg Hard CapsulesRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 17Document updated
Sources checked